Cargando…

Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus

Lung cancer stem cell (LCSC) is critical in cancer initiation, progression, drug resistance and relapse. Disadvantages showed in conventional lung cancer therapy probably because of its existence. In this study, lung cancer cell line A549 cells propagated as spheroid bodies (named as A549 sphere cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yu, Xu, Haineng, Huang, Weidan, Ding, Miao, Xiao, Jing, Yang, Dongmei, Li, Huaguang, Liu, Xin-Yuan, Chu, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420595/ https://www.ncbi.nlm.nih.gov/pubmed/25683371 http://dx.doi.org/10.1111/jcmm.12397

Ejemplares similares

Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
por: Xu, Haineng, et al.
Publicado: (2014)

Synergistic Suppression Effect on Tumor Growth of Colorectal Cancer by Combining Radiotherapy With a TRAIL-Armed Oncolytic Adenovirus
por: Gao, Hangxiang, et al.
Publicado: (2019)

Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
por: Tolksdorf, Beatrice, et al.
Publicado: (2021)

Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus
por: He, Xu, et al.
Publicado: (2023)

Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment
por: Gryciuk, Aleksander, et al.
Publicado: (2023)

Efficacy of a new oncolytic adenovirus armed with IL-13 against oral carcinoma models
por: Zhang, Kai-Liang, et al.
Publicado: (2019)

Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
por: Ang, Lin, et al.
Publicado: (2022)

Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma
por: Zou, Hai, et al.
Publicado: (2018)

Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia
por: Wang, Zixuan, et al.
Publicado: (2020)

Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma
por: Jiang, Shan, et al.
Publicado: (2023)

Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus
por: Havunen, Riikka, et al.
Publicado: (2018)

Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
por: Ono, Ryosuke, et al.
Publicado: (2022)

Combination of oncolytic adenovirus ZD55 harboring TRAIL-IETD-MnSOD and cytokine-induced killer cells against lung cancer
por: Jiang, Runde, et al.
Publicado: (2021)

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer
por: Ziauddin, Mohammed F, et al.
Publicado: (2010)

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy
por: Xu, Hai-Neng, et al.
Publicado: (2011)

Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
por: Liu, Xing, et al.
Publicado: (2020)

Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2012)

Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
por: Farrera-Sal, Martí, et al.
Publicado: (2020)

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)

Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014)

Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020)

Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)

Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021)

A Renaissance for Oncolytic Adenoviruses?
por: Blanchette, Paola, et al.
Publicado: (2023)

A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma
por: Oh, Eonju, et al.
Publicado: (2018)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2020)

Synergistic antitumor effects of CDK inhibitor SNS-032 and an oncolytic adenovirus co-expressing TRAIL and Smac in pancreatic cancer
por: Ge, Yun, et al.
Publicado: (2017)

"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014)

Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness
por: Farrera-Sal, Martí, et al.
Publicado: (2020)

Thioridazine has potent antitumor effects on lung cancer stem-like cells
por: Shen, Jiani, et al.
Publicado: (2017)

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2020)

CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy
por: Li, Xiaofei, et al.
Publicado: (2022)

CD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growth
por: Li, Gongchu, et al.
Publicado: (2015)

GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells
por: Zhang, Xinmin, et al.
Publicado: (2016)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018)

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hjgpc6g7b646a4102f7kk209fg